Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Blood Cells, Molecules & Diseases

• Publication date

  2010-10-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bcmd.2010.05.008PMID 20655775
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Leukaemogenesis: more than mutant genes

  2010cited by this paper
• Leukaemogenesis: more than mutant genes

  2010cited by this paper
• Radiation‐induced bystander effects in vivo are epigenetically regulated in a tissue‐specific manner

  2009cited by this paper
• Incorporation of 5-chlorocytosine into mammalian DNA results in heritable gene silencing and altered cytosine methylation patterns.

  2009cited by this paper
• DNA methylation, epimutations and cancer predisposition.

  2009cited by this paper
• Aberrant DNA methylation is a dominant mechanism in MDS progression to AML.

  2009cited by this paper
• Carcinogen-induced gene promoter hypermethylation is mediated by DNMT1 and causal for transformation of immortalized bronchial epithelial cells.

  2008cited by this paper
• Epigenetic Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemias

  2008cited by this paper
• Double Strand Breaks Can Initiate Gene Silencing and SIRT1-Dependent Onset of DNA Methylation in an Exogenous Promoter CpG Island

  2008cited by this paper
• DNA methylation profiling of myelodysplastic syndrome hematopoietic progenitor cells during in vitro lineage-specific differentiation.

  2007cited by this paper
• The human promoter methylome

  2007cited by this paper
• Changes in DNA methylation patterns in subjects exposed to low-dose benzene.

  2007cited by this paper
• Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia

  2006cited by this paper
• Stable loss of global DNA methylation in the radiation-target tissue--a possible mechanism contributing to radiation carcinogenesis?

  2005cited by this paper
• CpG island methylator phenotype in cancer

  2004influential reference
• Novel Antiangiogenic Therapies for Renal Cell Cancer

  2004cited by this paper
• Aberrant methylation of multiple tumor suppressor genes in acute myeloid leukemia

  2004cited by this paper
• Aberrant methylation of DAP-kinase in therapy-related acute myeloid leukemia and myelodysplastic syndromes.

  2004cited by this paper
• Methylation-associated silencing of the thrombospondin-1 gene in human neuroblastoma.

  2003cited by this paper
• Aberrant p15 gene promoter methylation in therapy‐related myelodysplastic syndrome and acute myeloid leukaemia: clinicopathological and karyotypic associations

  2003cited by this paper
• The World Health Organization (WHO) classification of the myeloid neoplasms.

  2002cited by this paper
• Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia.

  2002cited by this paper
• Methylation profiling in acute myeloid leukemia.

  2001cited by this paper
• E-cadherin expression is silenced by 5' CpG island methylation in acute leukemia.

  2000cited by this paper
• Hypermethylation of E-cadherin in leukemia.

  2000cited by this paper
• Regulation of Cadherin Adhesive Activity

  2000cited by this paper
• Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies.

  1999cited by this paper
• EXPRESSION OF THE CELL ADHESION MOLECULE E‐CADHERIN BY THE HUMAN BONE MARROW STROMAL CELLS AND ITS PROBABLE ROLE IN CD34+STEM CELL ADHESION

  1998cited by this paper
• International scoring system for evaluating prognosis in myelodysplastic syndromes.

  1997cited by this paper
• Dynamic control of cell-cell adhesion for multicellular organization.

  1993cited by this paper
• DNA Methylation

  1973cited by this paper
• The World Health Organization (who) Classification of the Myeloid Neoplasms

  year unknowncited by this paper

• From pathogenesis to management: therapy-related myeloid neoplasms in survivors of female-specific cancers

  2026cites this paper
• MIR4435-2HG as a possible novel predictive biomarker of chemotherapy response and death in pediatric B-cell ALL

  2024cites this paper
• A retrospective validation of the IPSS-M molecular score in primary and therapy-related myelodysplastic syndromes (MDS)

  2023cites this paper
• De Novo and Therapy-Related Myelodysplastic Syndromes: Analogies and Differences

  2022cites this paper
• E-cadherin is regulated by GATA-2 and marks the early commitment of mouse hematopoietic progenitors to the basophil and mast cell fates

  2021cites this paper
• The Methylation Status of the Epigenome: Its Emerging Role in the Regulation of Tumor Angiogenesis and Tumor Growth, and Potential for Drug Targeting

  2018cites this paper
• CDH1 (E-cadherin) expression independently affects clinical outcome in acute myeloid leukemia with normal cytogenetics

  2017cites this paper
• CHFR hypermethylation, a frequent event in acute myeloid leukemia, is independently associated with an adverse outcome

  2016cites this paper
• B-acute lymphoblastic leukemia occurring in two pediatric patients with a history of prior Wilms tumors

  2016cites this paper
• Apoptosis, DAP-Kinase1 Expression and the Influences of Cytokine Milieu and Mesenchymal Stromal Cells on Ex Vivo Expansion of Umbilical Cord Blood-Derived Hematopoietic Stem Cells

  2016cites this paper
• Quantitative Detection of ID4 Gene Aberrant Methylation in the Differentiation of Myelodysplastic Syndrome from Aplastic Anemia

  2015cites this paper
• THE ABERRANT PROMOTER HYPERMETHYLATION PATTERN OF THE ANTI - ANGIOGENIC TSP1 GENE IN EPITHELIAL OVARIAN CARCINOMA: AN INDIAN STUDY

  2015cites this paper
• Azacitidine in the front-line treatment of therapy-related myeloid neoplasms: a multicenter case series.

  2015cites this paper
• TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases

  2015cites this paper
• Artesunate Induces SKM-1 Cells Apoptosis by Inhibiting Hyperactive β-catenin Signaling Pathway

  2015cites this paper
• Aberrant DNA Methylation of CDH1, p16 and DAPK in Childhood Acute Lymphoblastic Leukemia

  2015cites this paper
• Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases.

  2015cites this paper
• Therapy-Related Acute Myeloid Leukemias

  2013cites this paper
• Role of DNA methylation in the pathogenesis and treatment of myelodysplastic syndromes.

  2013cites this paper
• The clinical importance of moderate/severe bone marrow fibrosis in patients with therapy-related myelodysplastic syndromes

  2013cites this paper
• Engineering mouse models with myelodysplastic syndrome human candidate genes; how relevant are they?

  2013cites this paper
• Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases

  2013cites this paper
• Genomic impact of transient low-dose decitabine treatment on primary AML cells.

  2013cites this paper
• Interface of Epigenetics and Carcinogenic Risk Assessment

  2012cites this paper
• Identification of genetic aberrations in myelodysplastic syndromes

  2012cites this paper
• Outcome of therapy-related myeloid neoplasms treated with azacitidine

  2012cites this paper
• Quantitative analyses of DAPK1 methylation in AML and MDS

  2012cites this paper
• Therapy-related myeloid neoplasms

  2011cites this paper
• Mediterranean Journal of Hematology and Infectious Diseases Perspectives Similarities and Differences between Therapy Leukemia

  2011cites this paper
• Response to 5‐azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy‐related myelodysplastic syndrome

  2011cites this paper
• Epigenomics in hematopoietic transplantation: novel treatment strategies.

  2011cites this paper
• Similarities and Differences Between Therapy-Related and Elderly Acute Myeloid

  2011cites this paper
• Methylation of H2AR29 is a novel repressive PRMT6 target

  2011cites this paper
• Epigenetically-targeted therapies for the treatment of hematological malignancies.

  2011cites this paper